Drag a card by its title · ⚙ to size, swap or remove

The company

ALX Oncology Holdings Inc.

ALXO · Nasdaq

Health CareBiotechnologyNot moving yet

ALXO stood above a rising 150-day average in 40 of the last 52 weekly readings, and has been out of that trend for the last 7 weeks. It is 33.7% below that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−9 points in four weeks); Health Care: 28% (−6 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 7
Industry in uptrend: 18% -9 in 4 wk
Insider buys, 12 months: $10.0M
Insider sales, 12 months: $85K
Officials’ trades on record: 0
Institutions holding: 93 (+28)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 40 of 52 weeks.

23 Apr – 22 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months1

Sale orders, 12 months7

Buyers · sellers1 · 2

Who	Did	Shares	Traded
Shelly WongSVP, FINANCE AND CAO	sold	573at $1.93	17 Aug 2026filed 18 Aug 2026
Jason LettmannCHIEF EXECUTIVE OFFICER	sold	2,230at $1.93	17 Aug 2026filed 18 Aug 2026
Shelly WongSVP, FINANCE AND CAO	sold	1,404at $2.04	1 Jul 2026filed 6 Jul 2026
Shelly PintoSVP, FINANCE AND CAO	sold	903at $2.17	19 Mar 2026filed 23 Mar 2026
Jason LettmannCHIEF EXECUTIVE OFFICER	sold	12,311at $2.17	19 Mar 2026filed 23 Mar 2026
Shelly PintoSVP, FINANCE AND CAO	sold	565at $2.27	18 Feb 2026filed 20 Feb 2026
Corey S. GoodmanDirector, 10% owner	bought	3,184,713at $1.57	2 Feb 2026filed 4 Feb 2026
Shelly PintoSVP, FINANCE AND CAO	sold	3,925at $1.11	6 Jan 2026filed 7 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders93+28 on the quarter

New · exited39 · 12

Reported value$214.6M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
RA CAPITAL MANAGEMENT, L.P.unchanged · filed 14 Aug 2026	13,011,849$26.9M	00.0%
venBio Partners LLCunchanged · filed 14 Aug 2026	12,884,638$26.7M	00.0%
BlackRock, Inc.added · filed 7 Aug 2026	7,399,530$15.3M	+6,951,731+1552.4%
Redmile Group, LLCreduced · filed 14 Aug 2026	7,392,504$15.3M	-571,684−7.2%
Blackstone Inc.added · filed 14 Aug 2026	6,593,543$13.6M	+766,999+13.2%
Driehaus Capital Management LLCadded · filed 14 Aug 2026	6,025,240$12.5M	+290,620+5.1%
SILVERARC CAPITAL MANAGEMENT, LLCnew · filed 13 Aug 2026	5,744,757$11.9M	+5,744,757
TCG Crossover Management, LLCreduced · filed 14 Aug 2026	5,655,487$11.7M	-7,356,362−56.5%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	4,973,436$10.3M	+793,700+19.0%
Vivo Capital, LLCunchanged · filed 14 Aug 2026	3,184,713$6.6M	00.0%